CompletedPhase 3

Intraoperative Celiac Plexus Neurolysis for Patients With Operable Pancreatic and Periampullary Cancer

United States438 participantsStarted 2008-09

Plain-language summary

Determine if the addition of an intraoperative ethanol celiac plexus neurolysis (alcohol block) in patients undergoing surgical intervention for pancreatic cancer will result in a decrease in cancer associated pain

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Preoperative imaging indicates possibility of resectable pancreatic cancer * Intraoperative biopsy histologically confirming pancreatic adenocarcinoma Exclusion Criteria: \-

What they're measuring

The primary endpoint is cancer related pain control.

Timeframe: Increased pain at 12 months in subjects with resectable tumors; increased pain at 3 months in subjects with unresectable tumors

Trial details

NCT IDNCT00806611

SponsorSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-04

View on ClinicalTrials.gov More Pancreatic Cancer trials